Fund shareholders of ALNYLAM PHARMACEUTICALS INC
ISIN US02043Q1076 · United States · LEI 529900S3ZI14OWRJII50
- Fund shareholders
- 737
- Of which ETFs
- 212 525 other funds
- Value held
- ≈ 21.6B $ 21.5B $ · 1.4B SEK · 14.6M €
- Share of capital
- 56.4 % of 133.8M shares on Jul 24, 2026
737 funds hold this company. This table lists the 733 that declare it in a regulatory filing. The other 4 publish their holdings in their own reports. The “Fund reports” tab lists them, with their weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Global X NASDAQ 100 Collar 95-110 ETF GLOBAL X FUNDS | 19 | 3.9K $ | 0.12 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Innovator Equity Premium Income - Daily PutWrite ETF Innovator ETFs Trust | 18 | 3.7K $ | 0.02 % | 0.00 % | as of Jul 31, 2026 ↗ |
| KraneShares InspereX Nasdaq Dynamic Buffered High Income Index ETF Krane Shares Trust | 17 | 5.1K $ | 0.20 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Morningstar Alternatives Fund Morningstar Funds Trust | 17 | 3.5K $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Storebrand Global Developed Markets Storebrand Asset Management AS | 16 | 50.4K SEK | 0.05 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Nasdaq-100 Dynamic Buffer ETF ProShares Trust | 14 | 4.2K $ | 0.18 % | 0.00 % | as of May 31, 2026 ↗ |
| Avantis Responsible U.S. Equity ETF American Century ETF Trust | 12 | 3.6K $ | 0.00 % | 0.00 % | as of May 31, 2026 ↗ |
| Global X U.S. 500 ETF GLOBAL X FUNDS | 9 | 2.7K $ | 0.06 % | 0.00 % | as of May 31, 2026 ↗ |
| Vox Populi ETF Advisors Series Trust | 9 | 1.8K $ | 0.03 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Defiance US 100 Tech Ex Software ETF ETF Series Solutions | 8 | 2.4K $ | 0.24 % | 0.00 % | as of Jun 30, 2026 ↗ |
| FIIG ESG STOCK PLAN FOR RETIREMENT Unified Series Trust | 6 | 1.8K $ | 0.44 % | 0.00 % | as of May 31, 2026 ↗ |
| FIIG STOCK FUND FOR RETIREMENT Unified Series Trust | 5 | 1.5K $ | 0.37 % | 0.00 % | as of May 31, 2026 ↗ |
| Milliman Healthcare Inflation Plus ETF Milliman Funds Trust | 5 | 1.5K $ | 0.15 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Milliman Healthcare Inflation Guard ETF Milliman Funds Trust | 2 | 602.1 $ | 0.06 % | 0.00 % | as of Jun 30, 2026 ↗ |
| Fidelity Dynamic Buffered Equity ETF Fidelity Greenwood Street Trust | 2 | 411 $ | 0.00 % | 0.00 % | as of Jul 31, 2026 ↗ |
| Longview Advantage ETF RBB Fund Trust | 1 | 302 $ | 0.00 % | as of May 31, 2026 ↗ | |
| AQR Alternative Risk Premia Fund AQR Funds | 1 | 301 $ | 0.00 % | as of Jun 30, 2026 ↗ | |
| CAIXABANK MULTISALUD, FI CAIXABANK ASSET MANAGEMENT SGIIC, S.A. | 3.9M € | 0.60 % | as of Dec 31, 2025 ↗ | ||
| BBVA GLOBAL DESARROLLO, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 3.7M € | 0.49 % | as of Dec 31, 2025 ↗ | ||
| MERCHFONDO, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 3.6M € | 2.04 % | as of Dec 31, 2025 ↗ | ||
| MERCH-UNIVERSAL, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 1.6M € | 1.78 % | as of Dec 31, 2025 ↗ | ||
| DUNAS SELECCIÓN USA ESG CUBIERTO FI DUNAS CAPITAL ASSET MANAGEMENT S.G.I.I.C., S.A. | 554.4K € | 0.16 % | as of Dec 31, 2025 ↗ | ||
| SIGMA INVESTMENT HOUSE HEALTHCARE, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 253.9K € | 0.65 % | as of Dec 31, 2025 ↗ | ||
| PATRIBOND, FI PATRIVALOR, SGIIC, S.A. | 203.1K € | 0.26 % | as of Dec 31, 2025 ↗ | ||
| PATRIVAL, FI PATRIVALOR, SGIIC, S.A. | 169.3K € | 0.25 % | as of Dec 31, 2025 ↗ | ||
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 146.6K € | 3.99 % | as of Dec 31, 2025 ↗ | ||
| FONDO NARANJA NASDAQ 100, FI AMUNDI IBERIA, SGIIC, S.A. | 129.7K € | 0.28 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 25, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 95.1K € | 0.01 % | as of Dec 31, 2025 ↗ | ||
| ARQUIA BANCA LIDERES DEL FUTURO, FI ARQUIGEST, S.A., S.G.I.I.C. | 77.8K € | 0.79 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 50, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 69.1K € | 0.03 % | as of Dec 31, 2025 ↗ | ||
| DIRECTOR GROWTH, FI INVERSIS GESTIÓN, S.A., SGIIC | 27.1K € | 0.81 % | as of Dec 31, 2025 ↗ | ||
| SABADELL PLANIFICACION, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 25.7K € | 0.01 % | as of Dec 31, 2025 ↗ | ||
| INVERSABADELL 70, FI SABADELL ASSET MANAGEMENT, S.A., S.G.I.I.C. | 24.4K € | 0.04 % | as of Dec 31, 2025 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 3.16 % | as of Sep 30, 2025 ↗ |
| Fidelity Funds - Global Healthcare Fund FIL Investment Management (Luxembourg) S.A. | 1.61 % | as of Apr 30, 2025 ↗ |
| Pictet - Quest AI-Driven Global Equities Pictet Asset Management (Europe) S.A. | 0.36 % | as of Sep 30, 2025 ↗ |
| Amundi Dynamique Climat Amundi Asset Management | 0.03 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| A&P LIFESCIENCE FUND, FI WELZIA MANAGEMENT, SGIIC, S.A. | 3.99 % | as of Dec 31, 2025 ↗ |
| Corgi Genomics & Precision Medicine ETF Corgi ETF Trust I | 3.88 % | as of Jun 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 3.83 % | as of Jun 30, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 3.62 % | as of Jul 31, 2026 ↗ |
| Horizon Kinetics Medical ETF Listed Funds Trust | 3.42 % | as of Jun 30, 2026 ↗ |
| American Century Mid Cap Growth Impact ETF American Century ETF Trust | 3.19 % | as of May 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3.19 % | as of May 31, 2026 ↗ |
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 3.17 % | as of Jul 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 3.16 % | as of Sep 30, 2025 ↗ |
| iShares Biotechnology ETF iShares Trust | 3.12 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 673 | -23 | 75,027,811 | -0.5 % |
| 2026Q2 | 696 | +10 | 75,428,168 | +1.0 % |
| 2026Q1 | 686 | +34 | 74,668,226 | +1.3 % |
| 2025Q4 | 652 | +34 | 73,684,788 | -2.6 % |
| 2025Q3 | 618 | -6 | 75,686,877 | +2.2 % |
| 2025Q2 | 624 | +46 | 74,063,375 | -0.1 % |
| 2025Q1 | 578 | -8 | 74,152,711 | -1.2 % |
| 2024Q4 | 586 | +51 | 75,034,343 | +9.1 % |
| 2024Q3 | 535 | +19 | 68,756,140 | +5.3 % |
| 2024Q2 | 516 | -5 | 65,297,179 | +1.9 % |
| 2024Q1 | 521 | -7 | 64,072,072 | -8.1 % |
| 2023Q4 | 528 | 69,739,098 |
Institutional managers
775 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| FMR LLC | 14,579,166 | 4.8B $ | as of Mar 31, 2026 |
| Capital World Investors | 10,802,348 | 3.6B $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 10,444,908 | 3.5B $ | as of Mar 31, 2026 |
| Capital Research Global Investors | 9,471,181 | 3.1B $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 6,323,752 | 2B $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 5,193,324 | 1.7M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 3,322,698 | 1.1B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,660,385 | 884.6M $ | as of Mar 31, 2026 |
| BAILLIE GIFFORD & CO | 2,493,866 | 825.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 1,992,577 | 659.3M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,935,925 | 640.5M $ | as of Mar 31, 2026 |
| Dodge & Cox | 1,929,253 | 638.3M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,802,363 | 596.3M $ | as of Mar 31, 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1,432,748 | 474.1K $ | as of Mar 31, 2026 |
| Clearbridge Investments, LLC | 1,356,036 | 448.7M $ | as of Mar 31, 2026 |
| Orbis Allan Gray Ltd | 1,334,825 | 441.7M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,291,726 | 427.4M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 1,099,318 | 363.7M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 1,059,062 | 350.4M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 1,002,681 | 331.8M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 966,912 | 319.9M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 934,881 | 309.3M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 913,104 | 297.9M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 858,120 | 283.9M $ | as of Mar 31, 2026 |
| Qube Research & Technologies Ltd | 838,187 | 277.3M $ | as of Mar 31, 2026 |
Funds holding the debt of ALNYLAM PHARMACEUTICALS INC
39 funds declare 48 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of ALNYLAM PHARMACEUTICALS INC". https://titelia.com/en/stocks/alnylam-pharmaceuticals-inc-US02043Q1076